BusinessTorrent Pharma Leads India's Generic Semaglutide Market with 38% Share
Ahmedabad-based Torrent Pharma has quickly become the leading player in India's generic semaglutide market, capturing nearly 38% market share within just one month of its launch, according to reports. This highlights Torrent's strong early position in the fast-growing diabetes treatment segment in India.
Business Medical Dialogues··Ahmedabad


